BPC-157 (10 mg) + TB-500 (10 mg) vial - peptides for recovery

While BPC-157 focuses on tissue protection and regeneration, TB500 primarily promotes healing and cell migration to damaged areas. Together, they support faster recovery from injuries, reduce inflammation, and improve overall health and well-being.

VIAL DETAILS:

10 mg BPC-157 + 10 mg thymosin beta 500/2 ml/vial. Provides a 4-week supply when following the standard dosing protocol of 10 units (0.5/0.5 mg) 5 times per week.

Keep refrigerated. Injection supplies and standard dosing instructions are included. 

Updated formula: Our combined peptide now contains thymosin beta 500 (TB500) instead of thymosin beta 4 (TB4) . TB500 is a fragment of TB4, which means it provides the same main benefits and functions. The composition, dosage, and therapeutic effects remain unchanged - support for reducing inflammation, tissue repair, and regeneration.

BENEFITS

Accelerated recovery from injuries: The combined action of BPC-157 and TB4 significantly enhances the body's natural healing response, making it beneficial for injuries such as ligament sprains, muscle strains, and ligament and tendon tears.

Reduced joint pain and inflammation: Both peptides have anti-inflammatory properties that help reduce joint pain and inflammation, which is particularly beneficial for people with chronic pain or arthritis.  

Improved tissue repair: This combination supports collagen production and angiogenesis, which are essential for tissue repair and regeneration, including muscles, ligaments, tendons, and skin.

Support for digestive system and organ health: BPC-157 in particular has a protective effect on the digestive system, promoting healing of the stomach and intestines. In combination with TB4, it further supports organ health by reducing inflammation.

Neuroprotective action and cardiovascular health: TB4 has neuroprotective properties and supports heart and cardiovascular health by stimulating the growth of new blood vessels. This makes the combination beneficial for overall cardiovascular health and recovery from heart injuries.

Support for long COVID-19 and chronic inflammation: The anti-inflammatory and healing properties of BPC-157 and TB4 may also be beneficial in addressing symptoms of long COVID-19, chronic inflammation, and tissue damage.

HOW IT WORKS

BPC-157, or Body Protection Compound 157, is a synthetic peptide consisting of 15 amino acids. Derived from a natural stomach protein, BPC-157 is highly valued for its regenerative properties and ability to support tissue repair. It promotes the development of new blood vessels (angiogenesis), increases collagen production for connective tissue healing, and reduces inflammation, supporting the healing of tendons, ligaments, and muscles. Thymosin beta-4 is a peptide naturally present in the body that plays an important role in tissue repair and regeneration. It reduces inflammation, promotes the formation of new blood vessels, and supports cell migration to damaged areas, accelerating the healing of soft tissues such as muscles, tendons, ligaments, and skin.

EXPECTED EFFECTS

1-2 weeks: Users often report initial improvements in reduced inflammation and pain relief. Increased mobility in damaged areas may also be observed during this period.

4-6 weeks:  Significant improvements in muscle and tendon recovery are generally reported. Studies indicate that users may observe a noticeable reduction in recovery time compared with standard healing rates.

8-12 weeks:  At this stage, long-term benefits are most noticeable, including improved tissue integrity, reduced scarring, and faster overall recovery. A pronounced anti-inflammatory effect and improved cardiovascular function also become apparent.

Long-term results:  Continued use under medical supervision may lead to lasting improvements in physical recovery, reduced chronic inflammation, and improved gastrointestinal health.

Use:

DOSAGE:

0.5/0.5 mg = 10 units per injection. NUMBER OF INJECTIONS PER WEEK: 

5 injections per week.

RECOMMENDED CYCLES:

3 months on (+), 1 month off (-). 

3 cycles per year.

INJECTION SITE:

For targeted pain relief, injections should be administered into subcutaneous fatty tissue (for example, in the abdomen, thigh, or arm) or directly into the area of injury or soreness.

TIME OF DAY:

BPC-157/TB500 can be administered at any time of day. 

Some people prefer to administer it in the morning or evening, depending on how it fits into their daily routine.

Composition:

BPC-157 (10 mg) + TB-500 (10 mg) 

Contraindications:

• Active cancer: Patients with active cancer should avoid BPC/TB4.

• Pregnant and breastfeeding women: The safety of these peptides during pregnancy or breastfeeding has not been established, so these groups should avoid them.

POSSIBLE SIDE EFFECTS

Injection-site reactions:  Common side effects include redness, swelling, or pain at the injection site, which are generally mild and resolve on their own.

Gastrointestinal symptoms:  Some users may experience mild stomach discomfort or nausea, especially when starting the medication.

Headaches and dizziness:  These side effects may occur, especially at the beginning of therapy.

TIPS FOR REDUCING SIDE EFFECTS

Start with a lower dose:  start therapy with a lower dose to assess how your body tolerates the medication, gradually increasing it to the desired level to minimize side effects such as headaches or gastrointestinal disturbances.

Rotate injection sites:  rotate injection sites to reduce irritation and prevent localized pain or swelling.

 If gastrointestinal symptoms occur, taking the peptides with food may help relieve these symptoms .

Drink enough fluids:  Adequate fluid intake is essential for reducing symptoms such as headaches and supporting overall metabolic function during therapy.

Consult your doctor regularly:  regular check-ups will help adjust the dosage, monitor side effects, and ensure the safety and effectiveness of treatment.

*All results are individual and depend on your health condition